The molecular and cellular origin of human prostate cancer - ScienceDirect
Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs - ScienceDirect
https://www.sciencedirect.com/science/article/pii/S0003999317312509 | Download Scientific Diagram
The molecular and cellular origin of human prostate cancer - ScienceDirect
Cancer Hallmark Automata (I): Model, Therapy and Complexity
The molecular and cellular origin of human prostate cancer - ScienceDirect
Metabolic oncology - Metaboog
PDF) Cancer Metastasis and the Immune System Response: CM-IS Modeling by Ising Model
Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs - ScienceDirect
VARIANCE-REDUCED SIMULATION OF MULTISCALE TUMOR GROWTH MODELING∗ 1. Introduction. Tumor growth is a complex biological phenome
Elucidating high-dimensional cancer hallmark annotation via enriched ontology - ScienceDirect
The molecular and cellular origin of human prostate cancer - ScienceDirect
Immune checkpoints | cytokines
Quante fasi ha un tumore?????
https://www.sciencedirect.com/science/article/pii/S2052297517301075 | Download Scientific Diagram
Elucidating high-dimensional cancer hallmark annotation via enriched ontology - ScienceDirect
Cancer Metastasis and the Immune System Response
Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs - ScienceDirect
Primary lung cancer samples cultured under microenvironment-mimetic conditions enrich for mesenchymal stem-like cells that promote metastasis | Scientific Reports
Advancing Systems Epidemiology in Cancer - 11. The Immuno-Carcinogen Theory of Cancer
Elucidating high-dimensional cancer hallmark annotation via enriched ontology - ScienceDirect
Elucidating high-dimensional cancer hallmark annotation via enriched ontology - ScienceDirect
High accuracy indicators of androgen suppression therapy failure for prostate cancer – a modeling study | medRxiv
Metabolic oncology - Metaboog
What Causes Cancer: Bad Luck or Bad Lifestyles? | Physics Forums
Vascular co-option - ScienceDirect
